ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 249 filers reported holding ALKERMES PLC in Q2 2018. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $11,536,000 | +5119.9% | 800 | -84.6% | 0.07% | +6700.0% |
Q3 2018 | $221,000 | -28.0% | 5,208 | -1.4% | 0.00% | -50.0% |
Q1 2018 | $307,000 | +38.9% | 5,282 | +31.8% | 0.00% | +100.0% |
Q4 2017 | $221,000 | -46.5% | 4,009 | -43.8% | 0.00% | -50.0% |
Q2 2017 | $413,000 | +2.0% | 7,135 | +2.9% | 0.00% | 0.0% |
Q1 2017 | $405,000 | +9.5% | 6,935 | +4.0% | 0.00% | 0.0% |
Q4 2016 | $370,000 | +18.6% | 6,669 | +0.7% | 0.00% | 0.0% |
Q3 2016 | $312,000 | +43.8% | 6,625 | +31.9% | 0.00% | +100.0% |
Q2 2016 | $217,000 | -77.5% | 5,021 | -58.7% | 0.00% | -83.3% |
Q4 2015 | $964,000 | +44.5% | 12,147 | +6.9% | 0.01% | +20.0% |
Q3 2015 | $667,000 | +40.4% | 11,364 | +53.8% | 0.01% | +66.7% |
Q2 2015 | $475,000 | +6.7% | 7,388 | +1.4% | 0.00% | 0.0% |
Q1 2015 | $445,000 | +4.7% | 7,287 | +0.6% | 0.00% | 0.0% |
Q4 2014 | $425,000 | +21.8% | 7,245 | -10.8% | 0.00% | +50.0% |
Q3 2014 | $349,000 | +8625.0% | 8,120 | +8726.1% | 0.00% | – |
Q1 2014 | $4,000 | – | 92 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 14,040,000 | $313,513,000 | 35.43% |
Krensavage Asset Management, LLC | 1,411,682 | $31,523,000 | 10.04% |
Prosight Management, LP | 502,150 | $11,213,000 | 6.01% |
Hardman Johnston Global Advisors LLC | 5,734,259 | $128,046,000 | 5.76% |
13D Management LLC | 415,055 | $9,268,000 | 4.85% |
Ally Bridge Group (NY) LLC | 300,000 | $6,699,000 | 4.42% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 593,000 | $13,248,000 | 4.25% |
GREAT POINT PARTNERS LLC | 507,500 | $11,332,000 | 2.73% |
Tamarack Advisers, LP | 200,000 | $4,466,000 | 2.62% |
Zebra Capital Management LLC | 22,134 | $494,000 | 1.88% |